Viral and Microbial Circulation Between Humans, Domesticated and Wild Animals Along an Ecotone, Democratic Republic of Congo
NCT04012164 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2024-03-27
Summary
This study will evaluate the overlap between the intestinal microbiome and virome of wild and domesticated animals and human beings living in close proximity in three sites along an ecotone (ecological gradient) in the Democratic Republic of Congo.
Conditions
- Zoonotic Disease
Interventions
- BIOLOGICAL
-
blood sampling
5ml blood sampling
- BIOLOGICAL
-
stool collection
self stool collection (2g)
- OTHER
-
Participatory activity and contact investigation
30 human subjects will self-report daily activities and contacts with selected wild and domesticated animals for five months.
- OTHER
-
Anthropological and historical interviews
Oral interviews on current and past practices and engagements with wild and domesticated animals will be conducted with the 30 human subjects who are recruited to self-report their activities (Participatory activity and contact investigation) and to provide blood and stool samples. Another 30 human subjects will be recruited only to participate in the same type of interviews, addressing past and present activities and relations with wild and domesticated animals.
Sponsors & Collaborators
-
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
collaborator OTHER -
Centre National de la Recherche Scientifique, France
collaborator OTHER -
University Paris 7 - Denis Diderot
collaborator OTHER -
Institut Pasteur
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-03-15
- Primary Completion
- 2021-09-21
- Completion
- 2021-09-21
Countries
- Democratic Republic of the Congo
Study Locations
More Related Trials
-
A Pilot Study Assessing Intestinal Microbiota Diversification and Changes After Travel to South(East) Asia From the US
NCT03043300 ·Status: COMPLETED
-
SARS-CoV-2 in Stools Compared to Respiratory Viral Strains.
NCT05567419 ·Status: UNKNOWN
-
Study of the Colonic Carriage of Staphylococcus Aureus in a Prospective Cohort of Patients Undergoing Endoscopic Screening for Digestive Cancer in the University Hospital of Saint-Etienne
NCT02502474 ·Status: COMPLETED ·Phase: NA
-
Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19.
NCT05107245 ·Status: COMPLETED
-
Microbiome Changes in Travelers to Tropical Destinations
NCT02295254 ·Status: UNKNOWN
-
Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France
NCT04325646 ·Status: COMPLETED
-
Washed Microbiota Transplantation for Clostridioides Difficile Infection
NCT06106698 ·Status: RECRUITING
-
Fecal Transplantation to Eradicate Colonizing Emergent Superbugs
NCT05035342 ·Status: RECRUITING ·Phase: PHASE3
-
Clostridioides Difficile Colonisation
NCT05693077 ·Status: RECRUITING ·Phase: PHASE1
-
The Effect of Faecal Microbiota Transplantation (FMT) on Eradication of Multidrug Resistant Organisms (MRO) in Intestinal Carriers
NCT05742074 ·Status: COMPLETED ·Phase: NA
-
C.Difficile Observational Study
NCT06277999 ·Status: COMPLETED
-
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
NCT07250724 ·Status: RECRUITING
-
Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2)
NCT04117113 ·Status: COMPLETED
-
Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms
NCT07265817 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Building an AI to Infer/Predict an Estimated Stool Microbiome Profile
NCT05847543 ·Status: COMPLETED
-
Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation
NCT02571062 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.
NCT02052726 ·Status: COMPLETED ·Phase: PHASE1
-
Profiling Fecal Samples for Selection of Donors of Feces
NCT04078581 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection
NCT01259726 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Influence of Diet on GI Health
NCT04783142 ·Status: COMPLETED ·Phase: NA
-
A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment Program
NCT03350711 ·Status: SUSPENDED
-
Predictive Value of the Immune Response of the Host in Clostridium Difficile Infections
NCT01946750 ·Status: COMPLETED ·Phase: NA
-
FMT for Lung and Associated-organ Rescue Efficacy in MDRO-infected Ventilated Patients
NCT06970262 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Household Transmission Dynamics of Multidrug Resistant Enterobacterales
NCT05798364 ·Status: RECRUITING
-
Digestive Microbiota Transplant
NCT03606031 ·Status: UNKNOWN